Thomas Beetham

Thomas Beetham

Verksamhetschef på VIRIDIAN THERAPEUTICS, INC.

Förmögenhet: 252 790 $ per 2026-07-31

57 år
Health Technology
Consumer Services
Commercial Services

Profil

Thomas W.
Beetham
was the founder of Kiniksa Pharmaceuticals Ltd., founded in 2015, where the titles held included Secretary, Chief Legal Officer & EVP-Operations from 2019 to 2021.
The current job is Chief Operating Officer at Viridian Therapeutics, Inc., starting in 2023.
Former jobs include Attorney at Palmer & Dodge LLP from 1999 to 2004, Attorney at Genzyme Corp.
from 2004 to 2011, General Legal Counsel at New England Biolabs, Inc. from 2011 to 2013, Chief Legal Officer, Senior VP & General Counsel at Synageva BioPharma Corp.
from 2013 to 2015, Secretary & Chief Legal Officer at Dianthus Therapeutics, Inc. from 2021 to 2023, and Chief Legal Officer at Magenta Therapeutics, Inc. from 2021 to 2023.
Education includes undergraduate studies at Rochester Christian University, graduate studies at Boston College Law School, and an MBA from Wallace E Carroll School of Management.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-03-31 13 361 ( 0,01 % ) 252 790 $ 2026-07-31

Aktiva positioner av Thomas Beetham

FöretagPositionStart
VIRIDIAN THERAPEUTICS, INC. Verksamhetschef 2023-10-30

Tidigare kända positioner av Thomas Beetham

FöretagPositionSlut
DIANTHUS THERAPEUTICS, INC. Generell Rådgivare 2023-09-01
MAGENTA THERAPEUTICS Generell Rådgivare 2023-09-01
Grundare 2021-06-01
SYNAGEVA BIOPHARMA CORP Generell Rådgivare 2015-06-01
Generell Rådgivare 2013-10-01
Se detaljerna i Thomas Beethams erfarenhet

Thomas Beethams utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

67

Första gradens relationer

11

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag11

Consumer Services

Health Technology

Commercial Services

Process Industries

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Thomas Beetham